Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05021146
Other study ID # DO-221014-COP
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date September 1, 2021
Est. completion date March 31, 2023

Study information

Verified date October 2021
Source Buda Health Center
Contact Aron Lazary, PhD
Phone +3618877900
Email aron.lazary@bhc.hu
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The specific objective of this study is to assess the safety and clinical efficacy of a new individualised spinal rehabilitation programme involving copaiba essential oil (CEO) therapy compared to usual care for people with chronic low back pain. Research in complementary and alternative medicine has increased over the last 15 years. As biochemical research shows, these substances carry the ability to relieve pain and to reduce inflammation. In doing so, it aims to: 1. Improve the health outcomes for individuals with chronic low back pain (CLBP) by positively impacting their pain, disability, work capacity, physical activity and mental health, and 2. Reduce the chronic health burden on society associated with treatment, sick leave, rehabilitation, and involuntary retirement, by reducing health-related costs. The primary clinical hypothesis is that patients with CLBP receiving individualised spinal care and additional CEO topical treatment will have superior short- and long-term outcome (defined by condition specific quality of life and general well-being) compared to usual care.


Recruitment information / eligibility

Status Recruiting
Enrollment 300
Est. completion date March 31, 2023
Est. primary completion date March 31, 2023
Accepts healthy volunteers No
Gender All
Age group 40 Years to 65 Years
Eligibility Inclusion Criteria: - Chronic low back pain with or without irradiating pain (pain > 3 months) - Low back pain is the dominant symptom, and Visual Analog Pain Scale (low back pain)>4 - Normal cognitive function, voluntary participation - Able to read and answer the questionnaires in English or Hungarian language Exclusion Criteria: - Previous spinal surgery - Untreated metabolic bone disease - Active malignant disease - Pregnancy - Severe osteoporosis, fracture or posttraumatic deformity - Spinal infection - Neuromuscular disease - Autoimmune disease - Myelopathy - Congenital spinal deformity - Mental disorders - Severe sciatica - Severe spinal instability - Refusing the study protocol

Study Design


Related Conditions & MeSH terms


Intervention

Other:
usual care and topical essential copaiba oil
All subjects will receive daily interdisciplinary - multimodular -treatment during their hospital stay including a daily 30 minute massage therapy. Both experimental groups and the placebo group patients continue to use topical treatment in the first half of the follow up period (90 days).
usual care and placebo treatment
All subjects will receive daily interdisciplinary - multimodular -treatment during their hospital stay including a daily 30 minute massage therapy. Both experimental groups and the placebo group patients continue to use topical treatment in the first half of the follow up period (90 days).
usual care
All subjects will receive daily interdisciplinary - multimodular -treatment during their hospital stay.

Locations

Country Name City State
Hungary National Center for Spinal Disorders / Buda Health Center Budapest

Sponsors (2)

Lead Sponsor Collaborator
Buda Health Center doTERRA International

Country where clinical trial is conducted

Hungary, 

Outcome

Type Measure Description Time frame Safety issue
Primary Pain intensity Visual Analogue Scale measured on a scale 0-10 where the higher the number the worse the pain intensity 6 months
Primary Function Oswestry Disability Index 6 months
Secondary Core Outcome Measures Index Back (COMI Back) A brief instrument for assessing the main outcomes of importance to patients with back problems (pain, function, symptom-specific well-being, quality of life, disability). 6 months
Secondary Quality of Life EuroQoL-5D 6 months
Secondary Psychological measurements- Fear Avoidance Beliefs Fear Avoidance Beliefs Questionnaire 6 months
Secondary Psychological measurements- Depression Beck Depression Inventory 6 months
Secondary Psychological measurements- Pain catastrophization: Pain Catastrophizing Scale 6 months
Secondary Psychological measurements- Anxiety State-Trait Anxiety Inventory 6 months
Secondary Spinal function Timed Up and Go (TUG) test 6 months
Secondary Spinal active range of motion range of motion 6 months
Secondary Global treatment outcome 7- point Likert scale ( higher numbers representing worse the outcome) 6 months
Secondary Patient satisfaction 5- point Likert scale (smaller number represent more satisfied patients) 6 months
Secondary Demand of treatment Pain medication and applied therapies after discharge 6 months
See also
  Status Clinical Trial Phase
Recruiting NCT05963451 - Brain, Psychological and Epigenetic Determinants for Optimizing the Treatment of Chronic Low Back Pain
Completed NCT04283370 - A Study Protocol Comparing a Home Rehabilitation Program Versus e-Health Program in Low Back Pain N/A
Completed NCT04824547 - Evaluation of Long-Term Continuity of Exercises in Low Back Pain Individuals N/A
Completed NCT04046419 - In Turkish Version "Health Care Providers and Impairment Relationship Scale (HC-PAIRS)"
Completed NCT04399772 - COgNitive FuncTional Therapy+ for Chronic Low Back paIn N/A
Recruiting NCT05780021 - Motivational Support Program in Chronic Low Back Pain After Multidisciplinary Functional Rehabilitation N/A
Completed NCT04555278 - Combining Non-invasive Brain Stimulation and Exercise to Treat Low Back Pain N/A
Completed NCT04530071 - Evaluation of Safety, Tolerability, and Efficacy of CordSTEM-DD in Patients With Chronic Low Back Pain Phase 1/Phase 2
Not yet recruiting NCT06347328 - The Benefits of Posterior Joint Infiltration in Chronic Low Back Pain N/A
Not yet recruiting NCT06080464 - Clinician Satisfaction With the VERABANDâ„¢ N/A
Not yet recruiting NCT04940715 - Efficacy of Passive Joint Mobilization vs Mobilization With Movement on Pain Processing in Patients With Chronic Low Back Pain N/A
Recruiting NCT04683718 - A First in Human Feasibility Study to Evaluate the Safety and Effectiveness of the BIOTRONIK Prospera SCS System With HomeStream Remote Management N/A
Recruiting NCT05724160 - Using Non-Weightbearing Stationary Elliptical Machines for Patients With Chronic Low Back Pain N/A
Recruiting NCT06030128 - Core Stabilization Exercise Therapy in Chronic Lower Back Back Management in Community Dwelling Older Adults N/A
Recruiting NCT05846087 - Mobile App-delivered Sleep Therapy (SleepFix) for Individuals With Chronic Low Back Pain and Insomnia N/A
Active, not recruiting NCT05396014 - The BEST Trial: Biomarkers for Evaluating Spine Treatments Phase 4
Active, not recruiting NCT06140862 - Ankle Spine Syndrome "RAFFET Syndrome II N/A
Completed NCT05512338 - Motivation and Adherence to Exercise Recommendations N/A
Completed NCT05120921 - Osteopathic Single CAse Research for Patients With Chronic Low Back Pain N/A
Completed NCT06423755 - Swimming Versus Standard Physiotherapy Care as Rehabilitation Modalities for Persistent Low Back Pain: Feasibility Study N/A